Downstream Effects of Mutations in SOD1 and TARDBP Converge on Gene Expression Impairment in Patient-Derived Motor Neurons.
Autorzy:
Dash BP; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany. Freischmidt A; Department of Neurology, Ulm University, 89081 Ulm, Germany. WeishauptJH; Division of Neurodegeneration, Department of Neurology, Mannheim Center for Translational Neurosciences, Medical Faculty Mannheim, Heidelberg University, 68167 Mannheim, Germany. Hermann A; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, 18147 Rostock, Germany.; Center for Transdisciplinary Neurosciences Rostock, University Medical Center Rostock, 18147 Rostock, Germany.; Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Rostock/Greifswald, 18147 Rostock, Germany.
Quadruple genetic variants in a sporadic ALS patient.
Autorzy:
Yilmaz R; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. Weishaupt K; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. Valkadinov I; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. Knehr A; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. Brenner D; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany. WeishauptJH; Division of Neurodegenerative Disorders, Department of Neurology, Medical Faculty Mannheim, Mannheim Center for Translational Neurosciences, Heidelberg University, Mannheim, Germany.
T-cell dysregulation is associated with disease severity in Parkinson's Disease.
Autorzy:
Bhatia D; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Grozdanov V; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Ruf WP; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Kassubek J; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany. Ludolph AC; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany.; German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany. WeishauptJH; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany.; Division for Neurodegenerative Diseases, Neurology Department, University Medicine Mannheim, Heidelberg University, Mannheim, Germany. Danzer KM; Neurology, University Clinic, University of Ulm, Albert-Einstein-Allee 11, 89081, Ulm, Germany. .; German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany. .
Pokaż więcej
Źródło:
Journal of neuroinflammation [J Neuroinflammation] 2021 Oct 30; Vol. 18 (1), pp. 250. Date of Electronic Publication: 2021 Oct 30.
A natural history comparison of SOD1-mutant patients with amyotrophic lateral sclerosis between Chinese and German populations.
Autorzy:
Tang L; Department of Neurology, Peking University Third Hospital, Beijing, 100191, China.; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, 100191, China. Dorst J; Department of Neurology, Ulm University, 89081, Ulm, Germany.; German Center for Neurodegenerative Diseases (DZNE), Ulm Site, 89081, Ulm, Germany. Chen L; Department of Neurology, Peking University Third Hospital, Beijing, 100191, China.; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, 100191, China. Liu X; Department of Neurology, Peking University Third Hospital, Beijing, 100191, China.; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, 100191, China. Ma Y; Department of Neurology, Peking University Third Hospital, Beijing, 100191, China.; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, 100191, China. Günther K; Department of Neurology, Ulm University, 89081, Ulm, Germany. Michels S; Department of Neurology, Ulm University, 89081, Ulm, Germany. Müller K; Department of Neurology, Ulm University, 89081, Ulm, Germany. Freischmidt A; Department of Neurology, Ulm University, 89081, Ulm, Germany. WeishauptJH; Department of Neurology, Ulm University, 89081, Ulm, Germany. Fan D; Department of Neurology, Peking University Third Hospital, Beijing, 100191, China. .; Beijing Key Laboratory of Biomarker and Translational Research in Neurodegenerative Diseases, Peking University Third Hospital, Beijing, 100191, China. . Ludolph AC; Department of Neurology, Ulm University, 89081, Ulm, Germany. .; German Center for Neurodegenerative Diseases (DZNE), Ulm Site, 89081, Ulm, Germany. .
Pokaż więcej
Źródło:
Translational neurodegeneration [Transl Neurodegener] 2021 Oct 28; Vol. 10 (1), pp. 42. Date of Electronic Publication: 2021 Oct 28.
Typ publikacji:
Comparative Study; Letter; Research Support, Non-U.S. Gov't
Chitotriosidase as biomarker for early stage amyotrophic lateral sclerosis: a multicenter study.
Autorzy:
Steinacker P; Department of Neurology, Ulm University, Ulm, Germany. Feneberg E; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Halbgebauer S; Department of Neurology, Ulm University, Ulm, Germany. Witzel S; Department of Neurology, Ulm University, Ulm, Germany. Verde F; Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan, Italy.; Department of Pathophysiology and Transplantation - 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, Italy. Oeckl P; Department of Neurology, Ulm University, Ulm, Germany. Van Damme P; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.; Department of Neurosciences, VIB - Center for Brain & Disease Research, Experimental Neurology - Laboratory of Neurobiology, KU Leuven - University of Leuven, Leuven, Belgium. Gaur N; Department of Neurology, Jena University Hospital, Jena, Germany. Gray E; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Grosskreutz J; Department of Neurology, Jena University Hospital, Jena, Germany. Jardel CG; Department of Metabolic Biochemistry, Hôpitaux Universitaires Pitié Salpeêtrière-Charles Foix, Paris, France. Kachanov M; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Kuhle J; Neurology, Departments of Biomedicine, Medicine and Clinical Research, University and University Hospital Basel, Basel, Switzerland. Lamari F; Department of Metabolic Biochemistry, Hôpitaux Universitaires Pitié Salpeêtrière-Charles Foix, Paris, France. Maceski A; Neurology, Departments of Biomedicine, Medicine and Clinical Research, University and University Hospital Basel, Basel, Switzerland. Del Mar Amador M; Neurological Diseases Department, Paris ALS Reference Center, Hôpitaux Universitaires Pitié Salpeêtrière-Charles Foix, Paris, France. Mayer B; Institute for Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. Morelli C; Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan, Italy. Petri S; Department of Neurology, Hannover Medical School, Hannover, Germany. Poesen K; Laboratory of Molecular Neurobiomarker Research, Leuven Brain Institute, KU Leuven and Laboratory Medicine, University Hospitals of Leuven, Leuven, Belgium. Raaphorst J; Department of Neurology, Amsterdam Neuroscience Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Salachas F; Neurological Diseases Department, Paris ALS Reference Center, Hôpitaux Universitaires Pitié Salpeêtrière-Charles Foix, Paris, France. Silani V; Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milan, Italy.; Department of Pathophysiology and Transplantation - 'Dino Ferrari' Center, Università degli Studi di Milano, Milan, Italy. Turner MR; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK. Verbeek MM; Departments of Neurology and Laboratory Medicine, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Volk AE; Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. WeishauptJH; Department of Neurology, Ulm University, Ulm, Germany. Weydt P; Department for Neurodegenerative Disorders and Gerontopsychiatry, Bonn University, Bonn, Germany. Ludolph AC; Department of Neurology, Ulm University, Ulm, Germany. Otto M; Department of Neurology, Ulm University, Ulm, Germany.
Protein Binding Partners of Dysregulated miRNAs in Parkinson's Disease Serum.
Autorzy:
Ruf WP; Department of Neurology, Ulm University, 89081 Ulm, Germany. Freischmidt A; Department of Neurology, Ulm University, 89081 Ulm, Germany.; German Center for Neurodegenerative Diseases (DNZE), 89081 Ulm, Germany. Grozdanov V; Department of Neurology, Ulm University, 89081 Ulm, Germany. Roth V; Department of Neurology, Ulm University, 89081 Ulm, Germany. Brockmann SJ; Department of Neurology, Ulm University, 89081 Ulm, Germany. Mollenhauer B; Department of Neurology, Universitätsmedizin Göttingen and Paracelsus-Elena-Klinik, 34128 Kassel, Germany. Martin D; Department of Neurology, Technische Universität München, 80333 Munich, Germany. Haslinger B; Department of Neurology, Technische Universität München, 80333 Munich, Germany. Fundel-Clemens K; Boehringer Ingelheim Pharma GmbH & Co. KG, Div. Research Department, 88400 Biberach, Germany. Otto M; Department of Neurology, Ulm University, 89081 Ulm, Germany. Arnim CV; Department of Geriatrics, Göttingen University, 37075 Göttingen, Germany. Holzmann K; Genomics-Core Facility, Center for Biomedical Research, University Hospital Ulm, 89081 Ulm, Germany. Ludolph AC; Department of Neurology, Ulm University, 89081 Ulm, Germany.; German Center for Neurodegenerative Diseases (DNZE), 89081 Ulm, Germany. WeishauptJH; Institute for Neurodegeneration, Universitätsmedizin Mannheim, 68167 Mannheim, Germany. Danzer KM; Department of Neurology, Ulm University, 89081 Ulm, Germany.
Pokaż więcej
Źródło:
Cells [Cells] 2021 Apr 02; Vol. 10 (4). Date of Electronic Publication: 2021 Apr 02.
Focus on the heterogeneity of amyotrophic lateral sclerosis.
Autorzy:
Bendotti C; Mario Negri-ALS Study Group, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. Bonetto V; Mario Negri-ALS Study Group, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. Pupillo E; Mario Negri-ALS Study Group, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy. Logroscino G; Department of Neurosciences and Sense Organs, Center for Neurodegenerative Diseases and the Aging Brain Università degli Studi di Bari, Bari; Fondazione Giovanni Panico Tricase, Lecce, Italy. Al-Chalabi A; Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK. Lunetta C; NEuroMuscular Omnicentre (NEMO), Serena Onlus Foundation, Milano, Italy. Riva N; Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milano, Italy. Mora G; Department of Neurorehabilitation, ICS Maugeri IRCCS, Milano, Italy. Lauria G; Unit of Neurology, Motor Neuron Disease Center, Fondazione IRCCS Istituto Neurologico 'Carlo Besta', Milan, Italy.; Department of Biomedical and Clinical Sciences 'Lduigi Sacco', University of Milan, Milan, Italy. WeishauptJH; Department of Neurology, Ulm University, Ulm, Germany. Agosta F; Neuroimaging Research Unit, Institute of Experimental Neurology (INSPE), Division of Neuroscience, IRCCS San Raffaele Scientific Institute and Vita-Salute San Raffaele University, Milano, Italy. Malaspina A; Blizard Institute, Queen Mary University of London, London, UK. Basso M; Mario Negri-ALS Study Group, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.; Department of Cellular, Computational and Integrative Biology (CIBIO), Università degli Studi di Trento, Trento, Italy. Greensmith L; Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK. Van Den Bosch L; Center for Brain & Disease Research (VIB) and Laboratory of Neurobiology (KU Leuven), Leuven, Belgium. Ratti A; Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milano, Italy.; Department of Medical Biotechnology and Translational Medicine, Università degli Studi di Milano, Milano, Italy. Corbo M; Department of Neurorehabilitation Sciences, Casa Cura Policlinico (CCP), Milano, Italy. Hardiman O; Academic Unit of Neurology, Trinity Biomedical Sciences Institute, Trinity College, Dublin, Ireland. Chiò A; 'Rita Levi Montalcini' Department of Neuroscience, Università degli Studi di Torino, Torino, Italy. Silani V; Department of Neurology - Stroke Unit and Laboratory of Neuroscience, Istituto Auxologico Italiano, IRCCS, Milano, Italy.; Department of Pathophysiology and Transplantation, 'Dino Ferrari' Center, Università degli Studi di Milano, Milano, Italy. Beghi E; Mario Negri-ALS Study Group, Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milano, Italy.
Phenotypes and malignancy risk of different FUS mutations in genetic amyotrophic lateral sclerosis.
Autorzy:
Naumann M; Department of Neurology, Technische Universität Dresden, Dresden, Germany.; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, 18147, Germany. Peikert K; Department of Neurology, Technische Universität Dresden, Dresden, Germany.; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, 18147, Germany. Günther R; Department of Neurology, Technische Universität Dresden, Dresden, Germany.; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany. van der Kooi AJ; Department of Neurology, Amsterdam UMC, Academic Medical Centre, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, the Netherlands. Aronica E; Amsterdam UMC, Department of (Neuro)Pathology, Amsterdam Neuroscience, University of Amsterdam, Amsterdam, The Netherlands. Hübers A; Department of Neurology, German Center for Neurodegenerative Diseases, University of Ulm, Ulm, Germany. Danel V; Centre expert pour la SLA et les maladies du motoneurone hôpital SALENGRO, CHU, Lille, France. Corcia P; Centre expert pour la SLA et les maladies du motoneurone hôpital SALENGRO, CHU, Lille, France. Pan-Montojo F; Department of Neurology, Klinikum der Universität München, Munich Cluster for Systems Neurology, SyNergy, Munich, 81377, Germany. Cirak S; Division of Pediatric Neurology, Department of Pediatrics, University Hospital Cologne, Cologne, Germany.; Center for Molecular Medicine, University of Cologne, Cologne, Germany. Haliloglu G; Department of Pediatric Neurology, Hacettepe University Children's Hospital, Ankara, 06100, Turkey. Ludolph AC; Department of Neurology, German Center for Neurodegenerative Diseases, University of Ulm, Ulm, Germany. Goswami A; Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, 3052074, Germany. Andersen PM; Institute of Pharmacology and Clinical Neuroscience, Umeå University, Umeå, SE-90185, Sweden. Prudlo J; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, 18147, Germany.; German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, 18147, Germany.; Department of Neurology, University of Rostock, Rostock, Germany. Wegner F; Department of Neurology, Hannover Medical School, Hannover, Germany. Van Damme P; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.; Department for Neuroscience, VIB-KU Leuven Center for Brain & Disease Research, Leuven, Belgium. WeishauptJH; Department of Neurology, German Center for Neurodegenerative Diseases, University of Ulm, Ulm, Germany. Hermann A; Department of Neurology, Technische Universität Dresden, Dresden, Germany.; German Center for Neurodegenerative Diseases (DZNE), Dresden, Germany.; Translational Neurodegeneration Section 'Albrecht-Kossel', Department of Neurology, University Medical Center Rostock, University of Rostock, Rostock, 18147, Germany.; German Center for Neurodegenerative Diseases (DZNE) Rostock/Greifswald, Rostock, 18147, Germany.; Center for Transdisciplinary Neurosciences Rostock (CTNR), University Medical Center Rostock, University of Rostock, Rostock, 18147, Germany.
Longitudinal diffusion tensor magnetic resonance imaging analysis at the cohort level reveals disturbed cortical and callosal microstructure with spared corticospinal tract in the TDP-43 ALS mouse model.
Autorzy:
Müller HP; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Brenner D; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Roselli F; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany.; 2German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany. Wiesner D; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Abaei A; 3Core Facility Small Animal MRI, University of Ulm, Ulm, Germany. Gorges M; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Danzer KM; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Ludolph AC; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Tsao W; 4Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, USA. Wong PC; 4Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, USA. Rasche V; 3Core Facility Small Animal MRI, University of Ulm, Ulm, Germany. WeishauptJH; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany. Kassubek J; 1Department of Neurology, University of Ulm, Oberer Eselsberg 45, RKU, D-89081 Ulm, Germany.
Pokaż więcej
Źródło:
Translational neurodegeneration [Transl Neurodegener] 2019 Aug 30; Vol. 8, pp. 27. Date of Electronic Publication: 2019 Aug 30 (Print Publication: 2019).
Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis.
Autorzy:
Rué L; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Oeckl P; Department of Neurology, Ulm University Hospital, Ulm, Germany. Timmers M; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Lenaerts A; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. van der Vos J; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Smolders S; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Poppe L; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. de Boer A; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Van Den Bosch L; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. Van Damme P; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium. WeishauptJH; Department of Neurology, Ulm University Hospital, Ulm, Germany. Ludolph AC; Department of Neurology, Ulm University Hospital, Ulm, Germany. Otto M; Department of Neurology, Ulm University Hospital, Ulm, Germany. Robberecht W; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium.; Department of Neurology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium. Lemmens R; Department of Neurosciences, Experimental Neurology and Leuven Brain Institute (LBI), KU Leuven - University of Leuven, Leuven, Belgium. .; Laboratory of Neurobiology, Center for Brain & Disease Research, VIB, KU Leuven, Leuven, Belgium. .; Department of Neurology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium. .
Exome array analysis of rare and low frequency variants in amyotrophic lateral sclerosis.
Autorzy:
Dekker AM; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. Diekstra FP; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. Pulit SL; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. Tazelaar GHP; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. van der Spek RA; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. van Rheenen W; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. van Eijk KR; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. Calvo A; Rita Levi Montalcini' Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy. Brunetti M; Rita Levi Montalcini' Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy. Damme PV; KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven, Research Institute for Neuroscience and Disease (LIND), B-3000, Leuven, Belgium.; VIB, Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium.; University Hospitals Leuven, Department of Neurology, Leuven, Belgium. Robberecht W; KU Leuven - University of Leuven, Department of Neurosciences, Experimental Neurology and Leuven, Research Institute for Neuroscience and Disease (LIND), B-3000, Leuven, Belgium.; VIB, Vesalius Research Center, Laboratory of Neurobiology, Leuven, Belgium.; University Hospitals Leuven, Department of Neurology, Leuven, Belgium. Hardiman O; Academic Unit of Neurology, Trinity College Dublin, Trinity Biomedical Sciences Institute, Dublin, Ireland.; Department of Neurology, Beaumont Hospital, Dublin, Ireland. McLaughlin R; Population Genetics Laboratory, Smurfit Institute of Genetics, Trinity College Dublin, Dublin, Ireland. Chiò A; Rita Levi Montalcini' Department of Neuroscience, ALS Centre, University of Torino, Turin, Italy. Sendtner M; Institute of Clinical Neurobiology, University of Würzburg, Würzburg, Germany. Ludolph AC; Department of Neurology, Ulm University, Ulm, Germany. WeishauptJH; Department of Neurology, Ulm University, Ulm, Germany. Pardina JSM; ALS Unit, Hospital San Rafael, Madrid, Spain. van den Berg LH; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. Veldink JH; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2019 Apr 11; Vol. 9 (1), pp. 5931. Date of Electronic Publication: 2019 Apr 11.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
